Is Erythrocyte Sedimentation Rate the Preferable Measure of the Acute Phase Response in Rheumatoid Arthritis?

Journal of Rheumatology

Volumn 31, Issue 5, 2004, Pages 838-840

  Paulus, Harold E ^a   Brahn, Ernest ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; MINOCYCLINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACUTE PHASE RESPONSE; EDITORIAL; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RHEUMATOID ARTHRITIS;

ACUTE-PHASE REACTION; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; HUMANS; RHEUMATOLOGY;

EID: 2342501847     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Ward MM. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis. J Rheumatol 2004;31:884-95.
2. Ballou SP, Kushner I. Laboratory evaluation of inflammation. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 4th ed. Philadelphia: W.B. Saunders Co.; 1993:671-9.
3. Brahn E, Scoville CD. Biochemical markers of disease activity. In: Bird H, Dixon JS, editors. Biochemical aspects of rheumatic diseases. Vol. 2. London: Bailliere Tindall; 1988:153-83.
4. Volkanis JE. Acute phase proteins in rheumatic disease. In: Koopman WJ, editor. Arthritis and allied conditions. 14th ed. Philadelphia: Lippincott Williams and Wilkins; 2001:504-14.
5. Pinals RS, Baum J, Bland J, et al. Preliminary criteria for remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
6. Van der Heijde DMFM, van't Hof MA, van Riel PLCM, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
7. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85.
8. Paulus HE, Ramos B, Wong WK, et al. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. J Rheumatol 1999;26:2324-31.
9. Dawes PT, Fowler PO, Clarke S, et al. Rheumatoid arthritis: treatment which controls C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44-9.
10. Yamanaka MY, Higami H, Kashiwazaki S. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. J Rheumatol 1998;25:427-32.